A Phase 1 Study of Concurrent Neoadjuvant Pembrolizumab Plus Chemoradiation Followed by Consolidation Pembrolizumab in Patients With Resectable Stage IIIA NSCLC
Jto Clinical And Research ReportsPeer ReviewedChristopher A. Lemmon +112022Journals
The content you want is available to Zendy users.
Already have an account? Sign inHaving issues? Contact support